Concepedia

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen

Sylvie Giacchetti, Raphaël Porcher, Anne de Roquancourt, C. Cuvier, P. Cottu, P Bertheau, M. Albiter, Fatiha Bouhidel, Florence Coussy, J.M. Extra,

British Journal of Cancer · 2014 · 31 citations · 35 references

DOIFull text

Open access

Concepts

References

35

Relaxing the Rule of Ten Events per Variable in Logistic and Cox Regression

Eric Vittinghoff, Charles E. McCulloch · American Journal of Epidemiology · 2006 · 4.1K citations

, , +13

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers

Peter C.C. Fong, David S. Boss, Timothy A. Yap et al. · New England Journal of Medicine · 2009 · 3.6K citations · Full text

, , +17

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess et al. · Journal of Clinical Oncology · 2008 · 2.9K citations · Full text

, , +16

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer et al. · Journal of Clinical Oncology · 2012 · 2.7K citations

, , +15

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

M. William Audeh, James Carmichael, Richard T. Penson et al. · The Lancet · 2010 · 2.3K citations

, , +16